IMMU-21. THE COMBINATION OF DELTA-24-ACT WITH AN IMMUNE CHECKPOINT INHIBITOR RESULTS IN ANTI-GLIOMA EFFECT AND IMMUNE MEMORY

MLA

Jaime Gallego Perez de Larraya, et al. “Immu-21. The Combination of Delta-24-Act with an Immune Checkpoint Inhibitor Results in Anti-Glioma Effect and Immune Memory.” Neuro-Oncology, vol. 22, Nov. 2020, p. ii109. EBSCOhost, https://doi.org/10.1093/neuonc/noaa215.451.

APA

Jaime Gallego Perez de Larraya, Marc Garcia-Moure, Zhihong Chen, Candelaria Gomez-Manzano, Juan Fueyo, Dolores Hambardzumyan, Sara Labiano, Daniel de la Nava, Marta M. Alonso, Montserrat Puigdelloses, & Virginia Laspidea. (2020). Immu-21. The Combination of Delta-24-Act with an Immune Checkpoint Inhibitor Results in Anti-Glioma Effect and Immune Memory. Neuro-Oncology, 22, ii109. https://doi.org/10.1093/neuonc/noaa215.451

Chicago

Jaime Gallego Perez de Larraya, Marc Garcia-Moure, Zhihong Chen, Candelaria Gomez-Manzano, Juan Fueyo, Dolores Hambardzumyan, Sara Labiano, et al. 2020. “Immu-21. The Combination of Delta-24-Act with an Immune Checkpoint Inhibitor Results in Anti-Glioma Effect and Immune Memory.” Neuro-Oncology 22 (November): ii109. doi:10.1093/neuonc/noaa215.451.